Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis - PubMed (original) (raw)
Comparative Study
Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis
Xiang Xu et al. Scand J Gastroenterol. 2002 Mar.
Abstract
Background: Mast cells have been implicated in chronic inflammatory conditions resulting in fibrosis, such as Crohn disease. However, a link between inflammation, fibrosis and mast cells has not been demonstrated in human or animal intestinal diseases. This work was undertaken to analyze whether mast cells play a role in inflammation and fibrosis in the TNBS-induced rat colitis.
Methods: Rats were rectally instilled 2,4,6,-trinitrobenzene sulfonic acid in ethanol, and immediately or 4 days later injected daily i.p. with nedocromil sodium, a mast cell stabilizer, compound 48/80, a mast cell activator, or saline. Rats were sacrificed 5 days post-TNBS, or on day 21. Intestinal inflammation and fibrosis were assessed by gross and histopathological evaluation. Colonic mast cell numbers (toluidine blue) and collagen (type I mRNA expression) were evaluated. Mast cell sonicate was added to rat colon fibroblasts. Fibroblast proliferation (3H-thymidine), collagen synthesis (3H-proline) and contractile activity (tridimensional collagen lattice contraction) were then assessed.
Results: Nedocromil reduced inflammation and fibrosis possibly by decreasing mast cell numbers and activation and consequent collagen production. Compound 48/80 slightly enhanced the severity of the disease by activating mast cells. Mast cells increased fibroblast proliferation, collagen production and contractile activity.
Conclusions: Mast cells are involved in the gastrointestinal tract inflammation and fibrosis of the TNBS-colitis rats.
Similar articles
- Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model.
Inoue K, Naito Y, Takagi T, Hayashi N, Hirai Y, Mizushima K, Horie R, Fukumoto K, Yamada S, Harusato A, Hirata I, Omatsu T, Yoshida N, Uchiyama K, Ishikawa T, Handa O, Konishi H, Wakabayashi N, Yagi N, Ichikawa H, Kokura S, Yoshikawa T. Inoue K, et al. Biol Pharm Bull. 2011;34(11):1659-65. doi: 10.1248/bpb.34.1659. Biol Pharm Bull. 2011. PMID: 22040876 - Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart.
Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL. Levick SP, et al. Hypertension. 2009 Jun;53(6):1041-7. doi: 10.1161/HYPERTENSIONAHA.108.123158. Epub 2009 Apr 27. Hypertension. 2009. PMID: 19398662 - Role of mast cells and myofibroblasts in human peritoneal adhesion formation.
Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Xu X, et al. Ann Surg. 2002 Nov;236(5):593-601. doi: 10.1097/00000658-200211000-00009. Ann Surg. 2002. PMID: 12409665 Free PMC article. - Mast cell-eosinophil-fibroblast crosstalk in allergic inflammation.
Smith SJ, Levi-Schaffer F. Smith SJ, et al. Chem Immunol. 2000;78:81-92. doi: 10.1159/000058808. Chem Immunol. 2000. PMID: 12847721 Review. No abstract available. - Mast cells, eosinophils and fibrosis.
Levi-Schaffer F, Weg VB. Levi-Schaffer F, et al. Clin Exp Allergy. 1997 May;27 Suppl 1:64-70. doi: 10.1111/j.1365-2222.1997.tb01829.x. Clin Exp Allergy. 1997. PMID: 9179448 Review.
Cited by
- Intestinal Epithelial Cell Brush Border Membrane Cl:HCO3 Exchanger Regulation by Mast Cells in Chronic Ileitis.
Paulraj RS, Afroz S, Palaniappan B, Murughiyan U, Singh S, Arthur S, Sundaram U. Paulraj RS, et al. Int J Mol Sci. 2024 Oct 18;25(20):11208. doi: 10.3390/ijms252011208. Int J Mol Sci. 2024. PMID: 39456989 Free PMC article. - The mast cell stimulator compound 48/80 causes urothelium-dependent increases in murine urinary bladder contractility.
Jones BM, Mingin GC, Tykocki NR. Jones BM, et al. Am J Physiol Renal Physiol. 2023 Jul 1;325(1):F50-F60. doi: 10.1152/ajprenal.00116.2023. Epub 2023 May 18. Am J Physiol Renal Physiol. 2023. PMID: 37199916 Free PMC article. - Is mastocytic colitis a specific clinical-pathological entity?
Vernia F, Tatti T, Necozione S, Capannolo A, Cesaro N, Magistroni M, Valvano M, Pompili S, Sferra R, Vetuschi A, Latella G. Vernia F, et al. Eur J Histochem. 2022 Nov 28;66(4):3499. doi: 10.4081/ejh.2022.3499. Eur J Histochem. 2022. PMID: 36440694 Free PMC article. - Telocytes' Role in Modulating Gut Motility Function and Development: Medical Hypotheses and Literature Review.
Banciu DD, Crețoiu D, Crețoiu SM, Banciu A, Popa D, David R, Berghea-Neamtu CS, Cipaian CR, Negrea MO, Gheonea M, Neamtu B. Banciu DD, et al. Int J Mol Sci. 2022 Jun 24;23(13):7017. doi: 10.3390/ijms23137017. Int J Mol Sci. 2022. PMID: 35806023 Free PMC article. Review. - Role of Macrophages and Mast Cells as Key Players in the Maintenance of Gastrointestinal Smooth Muscle Homeostasis and Disease.
Mischopoulou M, D'Ambrosio M, Bigagli E, Luceri C, Farrugia G, Cipriani G. Mischopoulou M, et al. Cell Mol Gastroenterol Hepatol. 2022;13(6):1849-1862. doi: 10.1016/j.jcmgh.2022.02.017. Epub 2022 Mar 2. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35245688 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources